BKYI - BIO-key International, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue4,044.5426,302.9842,975.7565,261.225
Cost of Revenue4,164.193,242.151729.6831,279.521
Gross Profit-119.6483,060.8332,246.0733,981.704
Operating Expenses
Research Development1,415.4011,659.8752,008.9421,556.025
Selling General and Administrative5,333.9065,676.3234,438.954,121.942
Non Recurring----
Others----
Total Operating Expenses10,913.49710,578.3497,177.5756,957.488
Operating Income or Loss-6,868.955-4,275.365-4,201.819-1,696.263
Income from Continuing Operations
Total Other Income/Expenses Net0.080.02712.115-161.043
Earnings Before Interest and Taxes-6,868.955-4,275.365-4,201.819-1,696.263
Interest Expense----192.199
Income Before Tax-6,868.875-4,275.338-4,189.704-1,857.306
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-6,868.875-4,275.338-4,189.704-1,857.306
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-6,868.875-4,275.338-4,189.704-1,857.306
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-8,495.874-5,044.496-4,992.204-1,991.157